Coalition for Epidemic Preparedness Innovations

Tweet this page
<
2020
2021
2022
2023
2024
>
Registration as it was on 28 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

1 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

14

Lobbying Costs over the years

  • Info

    Coalition for Epidemic Preparedness Innovations   (CEPI)

    EU Transparency Register

    852523338633-03 First registered on 18 Jun 2020

    Goals / Remit

    Our vision: Creating a world in which epidemics and pandemics are no longer a threat to humanity
    Our mission: to Accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in needs

    Main EU files targeted

    • Regulation (EU) 2021/695 of the European Parliament and of the Council of 28 April 2021 establishing Horizon Europe – the Framework Programme for Research and Innovation, laying down its rules for participation and dissemination, and repealing Regulations (EU) No 1290/2013 and (EU) No 1291/2013
    • Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014
    • Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014
    • Proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
    • Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
    • Council Recommendation on strengthened cooperation against vaccine-preventable diseases (2018/C 466/01)
    • EU Global Health Strategy to improve global health security and deliver better health for all

    Address

    Head Office
    Skøyen Atrium, Askekroken 11
    Oslo 0277
    NORWAY
    EU Office
    Skøyen Atrium, Askekroken 11
    Oslo 0277
    NORWAY

    Website

  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    25%4

    Lobbyists (Full time equivalent)

    1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    379,391,318€

    Major funding types in closed year

    Grants, Public financing, Other, Donations, Member's contribution

    Major contributions in closed year

    TypeNameAmount
    Contribution Government of Japan 95,292,167€
    Contribution Government of the United States of America 50,884,167€
    Contribution Wellcome Trust 39,115,266€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    The mission of the Coalition for Epidemic Preparedness Innovations (CEPI) is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. Since 2017, the joint partnership between CEPI and EC has generated many successes, especially reflected in the depth of collaboration of the CEPI- Health Emergency Preparedness and Response Authority of the European Commission (HERA) partnership from RVF work, to late stage CHIK development and human challenge models, which CEPI is keen to build on into 2024 and beyond. CEPI is also engaging with other parts of the EU, including across multiple Directorate-Generals, in order to promote synergies in investments to contribute to both European regional health security and global health security, develop common or more aligned approaches to vaccine libraries and enabling networks, and promote global equitable access in a globally coordinated response. CEPI’s work involves influencing the formulation of policies, legislative proposals, decisions and recommendations, through direct engagement with EC, participation in EC consultation or in studies commissioned by the EC, and supporting the implementation of relevant policies and programmes including via grants under Horizon 2020 and Horizon Europe. Activities to date have been conducted in line with the Letter of Intent Regarding Cooperation between CEPI and HERA. This includes a mandate for: regular, senior-level meetings to identify and discuss topics of mutual interest and review the progress of the cooperation; sharing of technical data and analysis, strategic insights and views on work plans; and exchange of information on related research, development, manufacturing and other priorities relevant for medical countermeasures in order to ensure cooperation on the overall priorities. Where relevant, HERA coordinates with other Commission services, acting as a contact point. The Letter of Intent is publicly available and can be found here: https://health.ec.europa.eu/document/download/291392aa-b829-4a8e-8bbc-6b56f7acc0b9_en?filename=hera_cepi_loi_en.pdf

    Other activities

    None declared

  • Meetings

    Meetings

    14 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 26 Jan 2024 Location online
      Subject End-to-end health security infrastructure in Rwanda
      DG Directorate-General for International Partnerships
      Attending
      • Koen Doens (Director-General)
    • Date 10 May 2023 Location Bruxelles
      Subject Meeting on preparedness for future cross border health emergencies
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Daphne von Buxhoeveden (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
      • Ines Prainsack (Cabinet member)
    • Date 09 Jan 2023 Location Brussels
      Subject Meeting with CEO of the Coalition for Epidemic Preparedness Innovations (CEPI).
      DG Research and Innovation
      Attending
      • Signe Ratso (Acting Director-General)
    • Date 06 Dec 2022 Location online
      Subject DG SANTE – CEPI bilateral meeting
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 10 Nov 2021 Location Videoconference
      Subject Pandemic preparedness and the industrial dimension of HERA
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 10 Nov 2021 Location Brussels
      Subject Strengthening pandemic preparedness and response: a dialogue with CEPI CEO Richard Hatchett and Bill &Melinda Gates Foundation co-chair Melinda French Gates.
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
      Other Lobbyists
    • Date 04 Oct 2021 Location Brussels
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 20 Jul 2021 Location Brussels
      Subject Vaccines and the way forward
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 18 Feb 2021 Location Virtual meeting
      Subject Discussion on the new coronavirus mutants, the HERA incubator, roll out of vaccines under COVAX and the vaccine sharing mechanism.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
    • Date 13 Jul 2020 Location Brussels (video conference)
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 19 Jun 2020 Location Brussels (Video conference)
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 10 Jun 2020 Location Brussels (video conference)
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 02 Jun 2020 Location Brussels (video conference)
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
      Other Lobbyists
    • Date 08 May 2020 Location Brussels (video-conference)
      Subject COVID-19
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
Download this datacard